Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to determine if CX157 is effective and safe in patients with treatment of treatment resistant depression over six weeks of treatment.
Epistemonikos ID: 85142290326250ec4b98ec153da0c23032e51802
First added on: May 06, 2024